全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Kosei Hasegawa , Masahiro Kagabu ...
来源:[J].Investigational New Drugs(IF 3.498), 2017, Vol.35 (6), pp.800-812
摘要:Objective Perifosine exhibits anti-tumor activity by inhibiting AKT phosphorylation. The purpose of this phase II basket trial was to evaluate the efficacy and safety of perifosine monotherapy for ovarian, endometrial, and cervical cancers. Methods Recurrent or persistent ovarian...
作者:Kosei Hasegawa , Miho Yamashita ...
来源:[J].Journal of Medical Case Reports, 2017, Vol.11 (1)
摘要:Stickler syndrome is a group of collagenopathies characterized by ophthalmic, skeletal, and orofacial abnormalities, with the degree of symptoms varying among patients. Mutations in the COL2A1 , COL11A1 , and COL11A2 procollagen genes cause Stickler syndrome. Marshall syndrome, c...
作者:Kosei Hasegawa , Tsukasa Baba ...
来源:[J].Gynecologic Oncology(IF 3.929), 2018, Vol.148 (2), pp.267-274
摘要:Abstract(#br)Objective(#br)To identify risk factors for venous thromboembolism (VTE) and to examine the association of VTE and survival in women with uterine carcinosarcoma.(#br)Methods(#br)This multicenter retrospective study examined 906 women who underwent primary surgica...
作者:... Junzo Hamanishi , Koji Matsuo , Kosei Hasegawa
来源:[J].Gynecologic Oncology(IF 3.929), 2018
摘要:Abstract(#br)Ovarian clear cell carcinoma (OCCC) is distinctive from other histological types of epithelial ovarian cancer, with genetic/epigenetic alterations, a specific immune-related molecular profile, and epidemiologic associations with ethnicity and endometriosis. Thes...
作者:Kosei Hasegawa , Keiichi Fujiwara ...
来源:[J].Gynecologic Oncology(IF 3.929), 2019, Vol.155 (2), pp.331-339
摘要:Abstract(#br)Introduction(#br)PI3K pathway signaling has received attention as a molecular target in clear cell ovarian carcinoma (CCOC). MDM2 is one of the AKT effectors in the PI3K pathway, which binds to and degrades p53. In this study, we aimed to clarify the prognostic signi...
作者:... Hiroshi Kajiwara , Kosei Hasegawa , Masanori Yasud
来源:[J].Surgical Oncology(IF 2.136), 2018, Vol.27 (3), pp.433-440
摘要:Abstract(#br)Objective(#br)To examine significance of sarcoma dominance (SD) patterns in uterine carcinosarcoma (UCS).(#br)Methods(#br)This is a secondary analysis of multicenter retrospective study examining women with stages I-IV UCS who underwent primary surgery. SD was d...
作者:Kosei Hasegawa , Erin A. Blake ...
来源:[J].Surgical Oncology(IF 2.136), 2019, Vol.29, pp.25-32
摘要:Abstract(#br)Objective(#br)To examine clinico-pathological characteristics and outcomes of uterine carcinosarcoma (UCS) in women aged ≥80 years.(#br)Methods(#br)This is a secondary analysis of a previous multicenter retrospective study examining 906 women with stage I–IV UCS...
作者:Kosei Hasegawa , Tsukasa Baba ...
来源:[J].Gynecologic Oncology(IF 3.929), 2017, Vol.145 (1), pp.78-87
摘要:Abstract(#br)Background(#br)To examine recurrence patterns in women with stage I uterine carcinosarcoma (UCS) stratified by adjuvant therapy pattern.(#br)Methods(#br)We examined 443 cases of stage I UCS derived from a retrospective cohort of 1192 UCS cases from 26 institutio...
作者:Kosei Hasegawa , Takayuki Enomoto ...
来源:[J].Gynecologic Oncology(IF 3.929), 2018, Vol.149 (2), pp.301-309
摘要:Abstract(#br)Objective(#br)To examine survival of women with stage I–II endometrioid endometrial cancer whose peritoneal cytology showed malignant or atypical cells (abnormal peritoneal cytology).(#br)Methods(#br)This is a multi-center retrospective study examining 1668 wome...
作者:Kosei Hasegawa , Erin A. Blake ...
来源:[J].Gynecologic Oncology(IF 3.929), 2017, Vol.147 (3), pp.565-571
摘要:Abstract(#br)Objective(#br)To examine survival after recurrence (SAR) among women with recurrent uterine carcinosarcoma who received a taxane/platinum doublet as the first-line salvage chemotherapy.(#br)Methods(#br)We retrospectively examined 148 women with recurrent uterine...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×